The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...